Rize Oncology Inc.
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 800.50K | 1.16M | 966.10K | 1.03M | 1.25M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 223.40K | 30.30K | 49.80K | 73.30K | 1.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.02M | 1.19M | 1.02M | 1.10M | 1.25M |
|
|
|||||
| Total Current Assets | 1.02M | 1.19M | 1.02M | 1.10M | 1.25M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.02M | 1.19M | 1.02M | 1.10M | 1.25M |
|
|
|||||
| Total Accounts Payable | 33.60K | 79.70K | 29.40K | 23.20K | 54.90K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 3.40K | -- | -- | -- |
| Total Other Current Liabilities | -- | 3.40K | -- | -- | -- |
| Total Current Liabilities | 33.60K | 83.10K | 29.40K | 23.20K | 54.90K |
|
|
|||||
| Total Current Liabilities | 33.60K | 83.10K | 29.40K | 23.20K | 54.90K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 33.60K | 83.10K | 29.40K | 23.20K | 54.90K |
|
|
|||||
| Common Stock & APIC | 6.35M | 5.86M | 5.86M | 5.84M | 5.83M |
| Retained Earnings | -5.10M | -4.83M | -4.66M | -4.53M | -4.43M |
| Treasury Stock & Other | -258.80K | 86.90K | -205.30K | -219.20K | -206.90K |
| Total Common Equity | 990.30K | 1.11M | 986.50K | 1.08M | 1.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 990.30K | 1.11M | 986.50K | 1.08M | 1.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 990.30K | 1.11M | 986.50K | 1.08M | 1.20M |
|
|
|||||